LexDanaLexDanabeta
Inventor

HIROYOSHI NISHIKAWA

Inventor
JP

Overview

3→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
PatentTitleYear
12,571,799Biomarkers for determining the efficacy of immune checkpoint inhibitors202612,240,903Biomarkers for determining the effectiveness of immune checkpoint inhibitors202511,505,605T cell-redirected antigen-binding molecule for cells having immunosuppression function2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to CHUGAI PHARMACEUTICAL CO LTD (1)· patent assignee history
2022Patents assigned to UNIV OSAKA (1)· patent assignee history
2022–2026Based in JP· patent location history
2025–2026Patents assigned to NAT CANCER CT (2)· patent assignee history
2025–2026Patents assigned to ONO PHARMACEUTICAL CO (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NAT CANCER CT22025–2026
ONO PHARMACEUTICAL CO22025–2026
CHUGAI PHARMACEUTICAL CO LTD12022
UNIV OSAKA12022
Locations
LocationPatentsSpan
JP32022–2026